BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22300792)

  • 1. Downregulation of PCDH9 predicts prognosis for patients with glioma.
    Wang C; Yu G; Liu J; Wang J; Zhang Y; Zhang X; Zhou Z; Huang Z
    J Clin Neurosci; 2012 Apr; 19(4):541-5. PubMed ID: 22300792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
    Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
    J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor.
    Schittenhelm J; Schwab EI; Sperveslage J; Tatagiba M; Meyermann R; Fend F; Goodman SL; Sipos B
    J Neuropathol Exp Neurol; 2013 Mar; 72(3):194-210. PubMed ID: 23399898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch1 is an independent prognostic factor for patients with glioma.
    Li J; Cui Y; Gao G; Zhao Z; Zhang H; Wang X
    J Surg Oncol; 2011 Jun; 103(8):813-7. PubMed ID: 21241024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ezrin expression in tissue microarray of primary and recurrent gliomas.
    Tynninen O; Carpén O; Jääskeläinen J; Paavonen T; Paetau A
    Neuropathol Appl Neurobiol; 2004 Oct; 30(5):472-7. PubMed ID: 15488023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of Jun activation domain-binding protein 1 and phosphorylated p27 expression in prognosis of glioma.
    He SM; Zhao ZW; Wang Y; Zhao JP; Wang L; Hou F; Gao GD
    Brain Tumor Pathol; 2012 Jan; 29(1):3-9. PubMed ID: 21837501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stratifin expression is a novel prognostic factor in human gliomas.
    Deng J; Gao G; Wang L; Wang T; Yu J; Zhao Z
    Pathol Res Pract; 2011 Nov; 207(11):674-9. PubMed ID: 21940111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global histone modification patterns as prognostic markers to classify glioma patients.
    Liu BL; Cheng JX; Zhang X; Wang R; Zhang W; Lin H; Xiao X; Cai S; Chen XY; Cheng H
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2888-96. PubMed ID: 20978174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas.
    Heimberger AB; McGary EC; Suki D; Ruiz M; Wang H; Fuller GN; Bar-Eli M
    Clin Cancer Res; 2005 Jan; 11(1):267-72. PubMed ID: 15671555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of low SLC22A18 expression with poor prognosis in patients with glioma.
    Chu SH; Ma YB; Feng DF; Zhang H; Zhu ZA; Li ZQ; Jiang PC
    J Clin Neurosci; 2012 Jan; 19(1):95-8. PubMed ID: 22153794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of PHLDA1 gene expression is associated with breast cancer progression.
    Nagai MA; Fregnani JH; Netto MM; Brentani MM; Soares FA
    Breast Cancer Res Treat; 2007 Nov; 106(1):49-56. PubMed ID: 17211533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of microRNA-205 as a potential prognostic indicator for human glioma.
    Hou SX; Ding BJ; Li HZ; Wang L; Xia F; Du F; Liu LJ; Liu YH; Liu XD; Jia JF; Li L; Wu ZL; Zhao G; Zhang ZG; Deng YC
    J Clin Neurosci; 2013 Jul; 20(7):933-7. PubMed ID: 23683741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
    Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
    Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of N-Myc downstream-regulated gene 4 influences patient survival in gliomas.
    Li S; Yang B; Li G; He S; Li Y
    Brain Tumor Pathol; 2013 Jan; 30(1):8-14. PubMed ID: 22399192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of NDRG2 is related to poor overall survival in patients with glioma.
    Li W; Chu D; Chu X; Meng F; Wei D; Li H; Sun B
    J Clin Neurosci; 2011 Nov; 18(11):1534-7. PubMed ID: 21872476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 1B1 expression in glial cell tumors: an immunotherapeutic target.
    Barnett JA; Urbauer DL; Murray GI; Fuller GN; Heimberger AB
    Clin Cancer Res; 2007 Jun; 13(12):3559-67. PubMed ID: 17575219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nestin expression in brain tumors: its utility for pathological diagnosis and correlation with the prognosis of high-grade gliomas.
    Arai H; Ikota H; Sugawara K; Nobusawa S; Hirato J; Nakazato Y
    Brain Tumor Pathol; 2012 Jul; 29(3):160-7. PubMed ID: 22350668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas.
    Heimberger AB; Abou-Ghazal M; Reina-Ortiz C; Yang DS; Sun W; Qiao W; Hiraoka N; Fuller GN
    Clin Cancer Res; 2008 Aug; 14(16):5166-72. PubMed ID: 18698034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between laminin-8 and glial tumor grade, recurrence, and patient survival.
    Ljubimova JY; Fugita M; Khazenzon NM; Das A; Pikul BB; Newman D; Sekiguchi K; Sorokin LM; Sasaki T; Black KL
    Cancer; 2004 Aug; 101(3):604-12. PubMed ID: 15274074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.